Swarnajayanti fellow from CDRI probing mitochondrion of malaria parasite for hints into alternative drug targets Read more
India’s pharmaceutical industry can meet requirements of the world, says WTO Director General Read more
Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI class in India, says GlobalData Read more
Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome in Australia Read more
Health Minister Mandaviya invites global investors from EXPO2020 to strengthen Make-in-India Read more